by
Lisa Chamoff, Contributing Reporter | October 24, 2022
From the October 2022 issue of HealthCare Business News magazine
Xoran Technologies
Last year, Xoran Technologies was notified of a grant award from the National Heart, Lung, and Blood Institute (NHLBI) to support the company’s research and development efforts for lung cone beam computed tomography (CBCT) imaging.
To accomplish the aims in the grant, Xoran has established collaborative partnerships with critical care pulmonology specialists and radiologists at the University of Michigan. The company has proposed an open-bore, mobile CT to assist in identification of lung disease.
Ad Statistics
Times Displayed: 19895
Times Visited: 372 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
“This grant allows Xoran to commercialize our future open-bore CT products quickly,” said Misha Rakic, Xoran’s chief executive officer. “This truly mobile device helps to support the diagnosis, triaging, and monitoring of the lungs of respiratory patients both in the intensive care unit, and in future respirator pandemic situations."
In August, Xoran received FDA 510(k) clearance for TRON, an open-bore fluoroscopy CT and X-ray device for full-body, low dose point-of-care imaging.
“With this TRON system, Xoran will have an open-bore CT application that can be used for full-body, low-dose imaging,” Rakic said. "In fact, the capability of a compact, lightweight CT that can be placed in a small van has the potential in the future to assist in democratizing access to CT imaging, whether it is for emergency stroke CT or lung screening CT.”
Back to HCB News
